Cytoreductive surgery is feasible in patients with limited regional platinum-resistant recurrent ovarian cancer.

Zou, Ruoyao; Jiang, Qidi; Luo, Xukai; Chen, Mo; Yuan, Lei; Yao, Liangqing

Zou, Ruoyao; Jiang, Qidi; Luo, Xukai; Chen, Mo; Yuan, Lei; Yao, Liangqing.

Afiliação

Zou R; Department of Gynecologic Oncology, Obstetrics and Gynecology Hospital of Fudan University, Shanghai, China.
Jiang Q; Department of Gynecologic Oncology, Obstetrics and Gynecology Hospital of Fudan University, Shanghai, China.
Luo X; Department of Gynecologic Oncology, Obstetrics and Gynecology Hospital of Fudan University, Shanghai, China.
Chen M; Department of Gynecologic Oncology, Obstetrics and Gynecology Hospital of Fudan University, Shanghai, China.
Yuan L; Department of Gynecologic Oncology, Obstetrics and Gynecology Hospital of Fudan University, Shanghai, China. ylfdfck@163.com.
Yao L; Department of Gynecologic Oncology, Obstetrics and Gynecology Hospital of Fudan University, Shanghai, China. yaoliangqing@163.com.

World J Surg Oncol ; 21(1): 375, 2023 Nov 30.

Article em En | MEDLINE | ID: mdl-38037085

Assuntos

Neoplasias Ovarianas; Humanos; Feminino; Neoplasias Ovarianas/tratamento farmacológico; Neoplasias Ovarianas/cirurgia; Neoplasias Ovarianas/patologia; Procedimentos Cirúrgicos de Citorredução; Estudos Retrospectivos; Recidiva Local de Neoplasia/tratamento farmacológico; Recidiva Local de Neoplasia/cirurgia; Carcinoma Epitelial do Ovário; Recidiva

Palavras-chave

Chemotherapy alone; Cytoreductive surgery; Limited regional recurrent; Platinum rechallenge; Platinum-resistant ovarian cancer

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Neoplasias Ovarianas Limite: Female / Humans Idioma: En Revista: World J Surg Oncol Ano de publicação: 2023 Tipo de documento: Article País de afiliação: China

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google